Secretory unit of islet in transplantation (SUIT) and engrafted islet rate (EIR) indexes are useful for evaluating single islet transplantation

Cell Transplantation

Volumn 17, Issue 1-2, 2008, Pages 121-128

  Noguchi, Hirofumi ^a,b,c   Yamada, Yuichiro ^d   Okitsu, Teru ^a   Iwanaga, Yasuhiro ^a   Nagata, Hideo ^e   Kobayashi, Naoya ^f   Hayashi, Shuji ^b   Matsumoto, Shinichi ^a,c,e  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

Engrafted islet rate; Islet transplantation; Non heart beating donors; Secretory unit of islet in transplantation

Indexed keywords

BASILIXIMAB; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; ENGRAFTMENT; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 42249115244     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000008783906991     Document Type: Conference Paper

References (42)

1. Baidal, D. A.; Froud, T.; Ferreira, J. V.; Khan, A.; Alejandro, R.; Ricordi, C. The bag method for islet cell infusion. Cell Transplant. 12:809-813; 2003.
2. Bank, H. L. Rapid assessment of islet viability with acridine orange and propidium iodide. In Vitro Cell Dev. Biol. 24:266-273; 1988.
3. Davalli, A. M.; Ogawa, Y.; Ricordi, C.; Scharp, D. W.; Bonner-Weir, S.; Weir, G. C. A selective decrease in the β cell mass of human islets transplanted into diabetic nude mice. Transplantation 59:817-820; 1995.
4. Davalli, A. M.; Ogawa, Y.; Scaglia, L.; Wu, Y. J.; Hollister, J.; Bonner-Weir, S.; Weir, G. C. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104-111; 1995.
5. Faradji, R. N.; Monroy, K.; Cure, P.; Froud, T.; Baidal, D.; Pileggi, A.; Messinger, S.; Ricordi, C.; Alejandro, R. C-peptide and glucose values in the peritransplant period after intraportal islet infusions in type 1 diabetes. Transplant. Proc. 37:3433-3434; 2005.
6. Froud, T.; Ricordi, C.; Baidal, D. A.; Hafiz, M. M.; Ponte, G.; Cure, P.; Pileggi, A.; Poggioli, R.; Ichii, H.; Khan, A.; Ferreira, J. V.; Pugliese, A.; Esquenazi, V. V.; Kenyon, N. S.; Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am. J. Transplant. 5:2037-2046; 2005.
7. Hering, B. J.; Kandaswamy, R.; Harmon, J. V.; Ansite, J. D.; Clemmings, S. M.; Sakai, T.; Paraskevas, S.; Eckman, P. M.; Sageshima, J.; Nakano, M.; Sawada, T.; Matsumoto, I.; Zhang, H. J.; Sutherland, D. E.; Bluestone, J. A. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am. J. Transplant. 4:390-401; 2004.
8. King, A.; Lock, J.; Xu, G.; Bonner-Weir, S.; Weir, G. C. Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia 48:2074-2079; 2005.
9. Korsgren, O.; Nilsson, B.; Bern, C.; Felldin, M.; Foss, A.; Kallen, R.; Lundgren, T.; Salmela, K.; Tibell, A.; Tufveson, G. Current status of clinical islet transplantation. Transplantation 79:1289-1293; 2005.
10. Lakey, J. R.; Warnock, G. L.; Rajotte, R. V.; Suarez-Alamazor, M. E.; Ao, Z.; Shapiro, A. M.; Kneteman, N. M. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61:1047-1053; 1996.
11. Markmann, J. F.; Deng, S.; Desai, N. M.; Huang, X.; Velidedeoglu, E.; Frank, A.; Liu, C.; Brayman, K. L.; Lian, M. M.; Wolf, B.; Bell, E.; Vitamaniuk, M.; Doliba, N.; Matschinsky, F.; Markmann, E.; Barker, C. F.; Naji, A. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 75:1423-1429; 2003.
12. Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Yamada, Y.; Fukuda, K.; Shibata, T.; Kasai, Y.; Maekawa, T.; Wada, H.; Nakamura, T.; Tanaka, K. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation 82:460-465; 2006.
13. Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Yamada, Y.; Fukuda, K.; Tsukiyama, K.; Suzuki, H.; Kawasaki, Y.; Shimodaira, M.; Matsuoka, K.; Shibata, T.; Kasai, Y.; Maekawa, T.; Shapiro, J.; Tanaka, K. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365:1642-1644; 2005.
14. Matsumoto, S.; Qualley, S. A.; Goel, S.; Hagman, D. K.; Sweet, I. R.; Poitout, V.; Strong, D. M.; Robertson, R. P.; Reems, J. A. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus 02) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 74:1414-1419; 2002.
15. Matsumoto, S.; Yamada, Y.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Nakai, Y.; Ueda, M.; Ishii, A.; Yabunaka, E.; Tanaka, K. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant. Proc. 37:3435-3437; 2005.
16. Matsumoto, S.; Zhang, G.; Qualley, S.; Clever, J.; Tombrello, Y.; Strong, D. M.; Reems, J. A. Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant. Proc. 36:1034-1036; 2004.
17. Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher, D. F.; Turner, R. C. Homeostasis model assessment: Insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419; 1985.
18. Nagata, H.; Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Yonekawa, Y.; Kinukawa, T.; Shimizu, T.; Miyakawa, S.; Shiraki, R.; Hoshinaga, K.; Tanaka, K. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation 82:327-331; 2006.
19. Noguchi, H.; Bonner-Weir, S.; Wei, F. Y.; Matsushita, M.; Matsumoto, S. BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 54:2859-2866; 2005.
20. Noguchi, H.; Iwanaga, Y.; Okitsu, T.; Nagata, H.; Yonekawa, Y.; Matsumoto, S. Evaluation of islet transplantation from non-heart beating donors. Am. J. Transplant. 6:2476-2482; 2006.
21. Noguchi, H.; Kaneto, H.; Weir, G. C.; Bonner-Weir, S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52:1732-1737; 2003.
22. Noguchi, H.; Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Yonekawa, Y.; Nagata, H.; Matsushita, M.; Wei, F. Y.; Matsui, H.; Minami, K.; Seino, S.; Masui, Y.; Futaki, S.; Tanaka, K. PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplant. 14:637-645; 2005.
23. Noguchi, H.; Matsumoto, S.; Matsushita, M.; Kobayashi, N.; Tanaka, K.; Matsui, H.; Tanaka, N. Immunosuppression for islet transplantation. Acta Med. Okayama 60:71-76; 2006.
24. Noguchi, H.; Matsushita, M.; Okitsu, T.; Moriwaki, A.; Tomizawa, K.; Kang, S.; Li, S. T.; Kobayashi, N.; Matsumoto, S.; Tanaka, K.; Tanaka, N.; Matsui, H. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. 10:305-309; 2004.
25. Noguchi, H.; Matsushita, M.; Matsumoto, S.; Lu, Y. F.; Matsui, H.; Bonner-Weir, S. Mechanism of PDX-1 protein transduction. Biochem. Biophys. Res. Commun. 332:68-74; 2005.
26. Noguchi, H.; Nakai, Y.; Ueda, M.; Masui, Y.; Futaki, S.; Kobayashi, N.; Hayashi, S.; Matsumoto, S. Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia 50:612-619; 2007.
27. Noguchi, H.; Nakai, Y.; Matsumoto, S.; Kawaguchi, M.; Ueda, M.; Okitsu, T.; Iwanaga, Y.; Yonekawa, Y.; Nagata, H.; Minami, K.; Masui, Y.; Futaki, S.; Tanaka, K. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am. J. Transplant. 5:1848-1855; 2005.
28. Noguchi, H.; Ueda, M.; Matsumoto, S.; Kobayashi, N.; Hayashi, S. BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans. Hum. Gene Ther. 18:10-17; 2007.
29. Noguchi, H.; Ueda, M.; Nakai, Y.; Iwanaga, Y.; Okitsu, T.; Nagata, H.; Yonekawa, Y.; Kobayashi, N.; Nakamura, T.; Wada, H.; Matsumoto, S. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am. J. Transplant. 6:496-504; 2006.
30. Noguchi, H.; Ueda, M.; Hayashii, S.; Kobayashi, N.; Okitsu, T.; Iwanaga, Y.; Nagata, H.; Nakai, Y.; Matsumoto, S. Ductal injection of preservation solution increases islet yields in islet isolation and improves islet graft function. Cell Transplant. 17:69-81; 2008.
31. Olsson, R.; Carlsson, P. O. Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia 48:469-476; 2005.
32. Ricordi, C. Islet transplantation: A brave new world. Diabetes 52:1595-1603; 2003.
33. Ricordi, C.; Gray, D. W.; Hering, B. J.; Kaufman, D. B.; Warnock, G. L.; Kneteman, N. M.; Lake, S. P.; London, N. J.; Socci, C.; Alejandro, R. Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27:185-195; 1990.
34. Ryan, E. A.; Lakey, J. R.; Paty, B. W.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Bigam, D.; Rajotte, R. V.; Shapiro, A. M. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157; 2002.
35. Ryan, E. A.; Lakey, J. R.; Rajotte, R. V.; Korbutt, G. S.; Kin, T.; Imes, S.; Rabinovitch, A.; Elliott, J. F.; Bigam, D.; Kneteman, N. M.; Warnock, G. L.; Larsen, I.; Shapiro, A. M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719; 2001.
36. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Lakey, J. R.; Bigam, D.; Shapiro, A. M. β-score: An assessment of β cell function after islet transplantation. Diabetes Care 28:343-347; 2005.
37. Saito, K.; Iwama, N.; Takahashi, T. Morphometrical analysis on topographical difference in size distribution, number and volume of islets in the human pancreas. Tohoku J. Exp. Med. 124:177-186; 1978.
38. Sawada, T.; Matsumoto, I.; Nakano, M.; Kirchhof, N.; Sutherland, D. E.; Hering, B. J. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 75:1965-1969; 2003.
39. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
40. Shapiro, A. M.; Ricordi, C.; Hering, B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 362:1242; 2003.
41. Wallace, T. M.; Levy, J. C.; Matthews, D. R. Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495; 2004.
42. Yamada, Y.; Fukuda, K.; Fujimoto, S.; Hosokawa, M.; Tsukiyama, K.; Nagashima, K.; Fukushima, M.; Suzuki, H.; Toyoda, K.; Sassa, M.; Funakoshi, S.; Inagaki, N.; Taniguchi, A.; Sato, T. S.; Matsumoto, S.; Tanaka, K.; Seino, Y. SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res. Clin. Pract. 74:222-226; 2006.